SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹16 Cr | ₹29 Cr | ₹13 Cr | ₹-2.83 Cr | ₹3.38 Cr |
What is the latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹-2.83 Cr |
| Mar2021 | ₹3.38 Cr |
How is Cash Flow from Financing Activities of SOTAC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | -45.43 | |
| Mar2024 | ₹29 Cr | 124.51 | |
| Mar2023 | ₹13 Cr | Positive | |
| Mar2022 | ₹-2.83 Cr | Negative | |
| Mar2021 | ₹3.38 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹123.2 Cr | -0.3% | -3.5% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,785.0 Cr | 0.4% | -4.6% | 6.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,242.0 Cr | 0.7% | -1.1% | 2.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,058.0 Cr | 2.9% | -1.2% | 42.7% | Stock Analytics | |
| CIPLA | ₹111,180.0 Cr | -1.5% | 5.5% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,149.0 Cr | 0.4% | -0.6% | 1.3% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -0.3% |
-3.5% |
-5.1% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses